Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Verano Biotechnology is a specialized biotechnology company based in Jinan, China, focusing on viral vector technology and gene therapy services. The company provides comprehensive CRO and CDMO solutions, including the design, construction, and packaging of Adeno-associated virus (AAV), lentivirus, and adenovirus vectors. Their expertise extends to CRISPR/Cas9 gene editing, plasmid production, and the development of stable cell lines to support basic research and clinical development. Verano Biotech serves a global clientele in the life sciences industry, aiming to accelerate the transition of gene therapies from the laboratory to the clinic. The company is recognized for its extensive library of ready-to-use viral products and its high-throughput manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Verano Biotechnology.